Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2015 (2015), Article ID 761867, 5 pages
http://dx.doi.org/10.1155/2015/761867
Research Article

Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature

1Chair and Rheumatology Unit, Medical School, Azienda Ospedaliero-Universitaria, Policlinico di Modena, University of Modena and Reggio Emilia, Via del Pozzo 71, 41100 Modena, Italy
2Institute of Obstetrics and Gynecology, Oncology Prevention Unit, University of Modena and Reggio Emilia, Modena, Italy

Received 19 August 2015; Revised 24 September 2015; Accepted 30 September 2015

Academic Editor: James R. Seibold

Copyright © 2015 M. Colaci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Onishi, D. Sugiyama, S. Kumagai, and A. Morinobu, “Cancer incidence in systemic sclerosis: meta-analysis of population-based cohort studies,” Arthritis and Rheumatism, vol. 65, no. 7, pp. 1913–1921, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Bonifazi, I. Tramacere, G. Pomponio et al., “Systemic sclerosis (scleroderma) and cancer risk: systematic review and meta-analysis of observational studies,” Rheumatology, vol. 52, no. 1, Article ID kes303, pp. 143–154, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Colaci, D. Giuggioli, C. Vacchi et al., “Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature,” Autoimmunity Reviews, vol. 13, no. 2, pp. 132–137, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. J. O. Parkhurst and M. Vulimiri, “Cervical cancer and the global health agenda: insights from multiple policy-analysis frameworks,” Global Public Health, vol. 8, no. 10, pp. 1093–1108, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Peirson, D. Fitzpatrick-Lewis, D. Ciliska, and R. Warren, “Screening for cervical cancer: a systematic review and meta-analysis,” Systematic Reviews, vol. 2, article 35, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. Committee on Practice Bulletins-Gynecology, “ACOG practice bulletin no. 131: screening for cervical cancer,” Obstetrics & Gynecology, vol. 120, no. 5, pp. 1222–1238, 2012. View at Publisher · View at Google Scholar
  7. H. Alhajeri, M. Hudson, M. Fritzler et al., “2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group,” Arthritis Care & Research, vol. 67, no. 4, pp. 582–587, 2015. View at Publisher · View at Google Scholar
  8. April 2015, http://www.rtm.unimo.it/pub2011.html.
  9. S. C. Duncan and R. K. Winkelmann, “Cancer and scleroderma,” The Journal of the American Medical Association, vol. 115, no. 8, pp. 950–955, 1979. View at Google Scholar · View at Scopus
  10. P. Lee, C. Alderdice, S. Wilkinson, E. C. Keystone, M. B. Urowitz, and D. D. Gladman, “Malignancy in progressive systemic sclerosis—association with breast carcinoma,” The Journal of Rheumatology, vol. 10, no. 4, pp. 665–666, 1983. View at Google Scholar · View at Scopus
  11. X. Kyndt, M. Hebbar, V. Queyrel, E. Hachulla, P. Y. Hatron, and B. Devulder, “Sclérodermie systémique et cancer. Recherche de facteurs prédictifs de cancer chez 123 patients sclérodermiques,” La Revue de Médecine Interne, vol. 18, no. 7, pp. 528–532, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Hill, A.-M. Nguyen, D. Roder, and P. Roberts-Thomson, “Risk of cancer in patients with scleroderma: a population based cohort study,” Annals of the Rheumatic Diseases, vol. 62, no. 8, pp. 728–731, 2003. View at Publisher · View at Google Scholar
  13. S. Chatterjee, G. W. Dombi, R. K. Severson, and M. D. Mayes, “Risk of malignancy in scleroderma: a population-based cohort study,” Arthritis and Rheumatism, vol. 52, no. 8, pp. 2415–2424, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. C. T. Derk, M. Rasheed, C. M. Artlett, and S. A. Jimenez, “A cohort study of cancer incidence in systemic sclerosis,” Journal of Rheumatology, vol. 33, no. 6, pp. 1113–1116, 2006. View at Google Scholar · View at Scopus
  15. A. B. Olesen, C. Sværke, D. K. Farkas, and H. T. Sørensen, “Systemic sclerosis and the risk of cancer: a nationwide population-based cohort study,” British Journal of Dermatology, vol. 163, no. 4, pp. 800–806, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. Airo', A. Ceribelli, I. Cavazzana, M. Taraborelli, S. Zingarelli, and F. Franceschini, “Malignancies in Italian patients with systemic sclerosis positive for anti-RNA polymerase III antibodies,” The Journal of Rheumatology, vol. 38, no. 7, pp. 1329–1334, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. L. Belloli, N. Carlo-Stella, N. Ughi, and B. Marasini, “Cancer in Italian patients with systemic sclerosis,” European Journal of Inflammation, vol. 9, no. 2, pp. 199–203, 2011. View at Google Scholar · View at Scopus
  18. É. Szekanecz, S. Szamosi, Á. Horváth et al., “Malignancies associated with systemic sclerosis,” Autoimmunity Reviews, vol. 11, no. 12, pp. 852–855, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Moinzadeh, C. Fonseca, M. Hellmich et al., “Association of anti-RNA polymerase III autoantibodies and cancer in scleroderma,” Arthritis Research and Therapy, vol. 16, article R53, 2014. View at Publisher · View at Google Scholar · View at Scopus
  20. A. A. Shah, L. K. Hummers, L. Casciola-Rosen, K. Visvanathan, A. Rosen, and F. M. Wigley, “Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma,” Arthritis & Rheumatology, vol. 67, no. 4, pp. 1053–1061, 2015. View at Publisher · View at Google Scholar
  21. A. Hashimoto, Y. Arinuma, T. Nagai et al., “Incidence and the risk factor of malignancy in Japanese patients with systemic sclerosis,” Internal Medicine, vol. 51, no. 13, pp. 1683–1688, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. C.-F. Kuo, S.-F. Luo, K.-H. Yu et al., “Cancer risk among patients with systemic sclerosis: a nationwide population study in Taiwan,” Scandinavian Journal of Rheumatology, vol. 41, no. 1, pp. 44–49, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Bernatsky, M. Hudson, J. Pope et al., “Reports of abnormal cervical cancer screening tests in systemic sclerosis,” Rheumatology, vol. 48, no. 2, pp. 149–151, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Esmaeili and K. Ghahremanzadeh, “Association of Pap smear abnormalities with autoimmune disorders,” Pakistan Journal of Biological Sciences, vol. 14, no. 10, pp. 600–604, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Schiffman, G. Clifford, and F. M. Buonaguro, “Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline,” Infectious Agents and Cancer, vol. 4, no. 1, article 8, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Martin, C. Mougin, J. L. Prétet et al., “Screening of human papillomavirus infection in women with systemic sclerosis,” Clinical and Experimental Rheumatology, vol. 32, 6, supplement 86, pp. S145–S148, 2014. View at Google Scholar
  27. 2015, http://www.epicentro.iss.it/passi/rapporto2012/ScreeningCervicale.asp.